General Information of the Compound
| Compound ID |
CP0103402
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
8-((cis, rac)-2-hydroxy-2-pyridin-2-yl-cyclohexyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H30N4O2
|
||||||||||||||||||
| Molecular Weight |
406.53
|
||||||||||||||||||
| Canonical SMILES |
O[C@]1(CCCC[C@H]1N1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H30N4O2/c29-22-23(28(18-26-22)19-8-2-1-3-9-19)13-16-27(17-14-23)21-11-4-6-12-24(21,30)20-10-5-7-15-25-20/h1-3,5,7-10,15,21,30H,4,6,11-14,16-18H2,(H,26,29)/t21-,24-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VOWCZDGOCSGDQG-ZJSXRUAMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT01360, Nociceptin receptor